Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Modulation Therapeutics in September, 2018 for $1,929,583.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA221554-02 | Phase II | 1,929,583 | September 1, 2018 | |||||||
A STTR Phase II contract was awarded to Modulation Therapeutics in September, 2018 for $2,000,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 2R42CA195946-02A1 | Phase II | 2,000,000 | September 1, 2018 | |||||||
A SBIR Phase I contract was awarded to Modulation Therapeutics in September, 2018 for $248,155.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43CA235992-01 | Phase I | 248,155 | September 18, 2018 | |||||||
A SBIR Phase I contract was awarded to Modulation Therapeutics in September, 2022 for $399,986.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA272064-01A1 | Phase I | 399,986 | September 15, 2022 | |||||||
A STTR Phase I contract was awarded to Modulation Therapeutics in February, 2019 for $258,700.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41NS110070-01 | Phase I | 258,700 | February 15, 2019 | |||||||
A STTR Phase I contract was awarded to Modulation Therapeutics in August, 2017 for $283,986.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA210669-01A1 | Phase I | 283,986 | August 28, 2017 | |||||||
A STTR Phase I contract was awarded to Modulation Therapeutics in March, 2016 for $279,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA195946-01A1 | Phase I | 279,000 | March 5, 2016 | |||||||
A STTR Phase I contract was awarded to Modulation Therapeutics in July, 2015 for $244,801.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA196026-01 | Phase I | 244,801 | July 24, 2015 | |||||||
A SBIR Phase I contract was awarded to Modulation Therapeutics in September, 2017 for $242,056.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA221554-01 | Phase I | 242,056 | September 25, 2017 | |||||||
A SBIR Phase I contract was awarded to Modulation Therapeutics for $299,336.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201500067C-0-0-0 | Phase I | 299,336 | ||||||||
A SBIR Phase I contract was awarded to Modulation Therapeutics for $218,817.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA171367-01A1 | Phase I | 218,817 | ||||||||
A SBIR Phase I contract was awarded to Modulation Therapeutics for $156,202.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA167998-01A1 | Phase I | 156,202 | ||||||||
A SBIR Phase I contract was awarded to Modulation Therapeutics for $288,301.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43CA180308-01 | Phase I | 288,301 | ||||||||
A STTR Phase I contract was awarded to Modulation Therapeutics for $225,000.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41CA183266-01 | Phase I | 225,000 | ||||||||
A SBIR Phase II contract was awarded to Modulation Therapeutics for $1,999,987.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201700035C-0-0-0 | Phase II | 1,999,987 | ||||||||
A STTR Phase I contract was awarded to Modulation Therapeutics in May, 2023 for $344,919.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41DK131705-01A1 | Phase I | 344,919 | May 1, 2023 | |||||||
A SBIR Phase II contract was awarded to Modulation Therapeutics in September, 2023 for $1,301,808.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA272064-02 | Phase II | 1,301,808 | September 1, 2023 |